Clinical trial
Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for…
NCT00379808 · University of Florida, Other · Completed
Key facts
| NCT number | NCT00379808 |
|---|---|
| Title | Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease |
| Official title | Role of the Arachidonate 5-Lipoxygenase Pathway in Coronary Heart Disease |
| Lead sponsor | University of Florida, Other |
| Collaborators | American Heart Association |
| Status | Completed |
| Study type | Interventional |
| Conditions | Coronary Heart Disease |
| Intervention type | Drug |
| Interventions | montelukast, Placebo |
| Enrollment | 22 |
| Start date | Jul 1, 2006 |
| Primary completion | Jul 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Sep 22, 2006 |
| Last update posted | Jul 23, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: